DRAVET SYNDROME
Clinical trials for DRAVET SYNDROME explained in plain language.
Never miss a new study
Get alerted when new DRAVET SYNDROME trials appear
Sign up with your email to follow new studies for DRAVET SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Extended safety check for promising seizure drug shows promise
Disease control CompletedThis study followed 412 patients with rare, severe seizure disorders like Dravet and Lennox-Gastaut syndromes to check the long-term safety of an add-on medication called ZX008 (fenfluramine). Participants had already taken the drug in earlier studies and continued it here to mon…
Matched conditions: DRAVET SYNDROME
Phase: PHASE3 • Sponsor: Zogenix, Inc. • Aim: Disease control
Last updated Apr 03, 2026 22:56 UTC
-
Year-Long epilepsy drug trial tests safety in devastating childhood conditions
Disease control CompletedThis study tested the long-term safety of an experimental epilepsy drug called LP352 in people with severe, difficult-to-treat epilepsy syndromes like Dravet and Lennox-Gastaut. It followed 41 participants for up to 52 weeks to monitor side effects and see how well the drug conti…
Matched conditions: DRAVET SYNDROME
Phase: PHASE2 • Sponsor: Longboard Pharmaceuticals • Aim: Disease control
Last updated Apr 03, 2026 22:56 UTC
-
Scientists test Easier-to-Swallow liquid for severe childhood epilepsy
Knowledge-focused CompletedThis study tested how the body absorbs a new liquid form of the drug stiripentol, used for a severe form of childhood epilepsy called Dravet syndrome. Researchers compared it to the standard capsule form in 24 healthy adults to see if they work similarly. The goal is to provide a…
Matched conditions: DRAVET SYNDROME
Phase: PHASE1 • Sponsor: Biocodex • Aim: Knowledge-focused
Last updated Mar 16, 2026 15:24 UTC